Experimental Autoimmune Uveoretinitis
Research from Hokkaido University provides new data on experimental autoimmune uveoretinitis
Published in Medical Letter on the CDC and FDA, May 16th, 2010
New research, 'Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice,' is the subject of a report. "Experimental autoimmune uveoretinitis (EAU), a Th1/Th17 cell-mediated autoimmune disease induced in mice, serves as a model of human endogenous uveitis. In this model, proinflammatory cytokines and various stimuli activate the transcriptional factor, nuclear factor-kappaB (NF-kappaB), in the retina," scientists in Sapporo, Japan report.
"The therapeutic effect of the NF-kappaB inhibitor, dehydroxy methyl epoxyquinomicin (DHMEQ), was examined on EAU. EAU was induced in B10.BR mice by K2 peptide...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Eukaryotic Research
Data on eukaryotic research reported by T.J. Lott and co-researchers - Public Health
Data on public health detailed by R. Kobau and co-authors - Hemophilia
Findings from National Center on Birth Defects and Developmental Disabilities advance knowledge in hemophilia - Bird Flu
Findings in bird flu reported from A.L. Balish and co-researchers - Antiretrovirals
New findings from K. Buchacz and co-authors in the area of antiretrovirals published - Coagulation
New findings from National Center on Birth Defects and Developmental Disabilities in the area of coagulation published - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
